| 000 | 01746 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250511223034.0 | ||
| 264 | 0 | _c19900705 | |
| 008 | 199007s 0 0 eng d | ||
| 022 | _a0002-9343 | ||
| 024 | 7 |
_a10.1016/0002-9343(90)90523-g _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrimble, M | |
| 245 | 0 | 0 |
_aThe antiphospholipid syndrome: prevalence among patients with stroke and transient ischemic attacks. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cJun 1990 |
||
| 300 |
_a593-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAutoantibodies _xanalysis |
| 650 | 0 | 4 | _aBlood Coagulation |
| 650 | 0 | 4 |
_aBlood Coagulation Disorders _xepidemiology |
| 650 | 0 | 4 |
_aBlood Coagulation Factors _xanalysis |
| 650 | 0 | 4 |
_aCardiolipins _ximmunology |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xepidemiology |
| 650 | 0 | 4 | _aLupus Coagulation Inhibitor |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhospholipids _ximmunology |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSyndrome |
| 700 | 1 | _aBell, D A | |
| 700 | 1 | _aBrien, W | |
| 700 | 1 | _aHachinski, V | |
| 700 | 1 | _aO'Keefe, B | |
| 700 | 1 | _aMcLay, C | |
| 700 | 1 | _aBlack, J | |
| 773 | 0 |
_tThe American journal of medicine _gvol. 88 _gno. 6 _gp. 593-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9343(90)90523-g _zAvailable from publisher's website |
| 999 |
_c2118120 _d2118120 |
||